Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Targeted inhibition of STATs and IRFs as a potential treatment strategy in cardiovascular disease

5 May 2016

Abstract excerpt

// Malgorzata Szelag 1 , Anna Piaszyk-Borychowska 1 , Martyna Plens-Galaska 1 , Joanna Wesoly 2 and Hans A.R. Bluyssen 1 1 Department of Human Molecular Genetics, Institute of Molecular Biology and Biotechnology, Faculty of Biology, Adam Mickiewicz University, Poznan, Poland 2 Laboratory of High Throughput Technologies, Institute of Molecular Biology and Biotechnology, Faculty of Biology, Adam Mickiewicz...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Atherosclerosis and Cardiovascular Diseases
Share to Cytokine Signaling Pathways and Interactions
Share to interferon and immune responses

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 27166190
DOI: 10.18632/oncotarget.9195

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Targeted inhibition of STATs and IRFs as a potential treatment strategy in cardiovascular diseasePMID 27166190Read ↗

Identification of ALEKSIN as a novel multi-IRF inhibitor of IRF- and STAT-mediated transcription in vascular inflammation and atherosclerosisSemantic proximity Read ↗

STAT1 and IRF8 in Vascular Inflammation and Cardiovascular Disease: Diagnostic and Therapeutic PotentialSemantic proximity Read ↗

The interferon regulatory factors as novel potential targets in the treatment of cardiovascular diseasesSemantic proximity Read ↗

STAT3: A Potential Drug Target for Tumor and InflammationSemantic proximity Read ↗

IRF9 and STAT1 as biomarkers involved in T-cell immunity in atherosclerosisSemantic proximity Read ↗

The Role of JAK/STAT Signaling Pathway and Its Downstream Influencing Factors in the Treatment of AtherosclerosisSemantic proximity Read ↗

A STAT inhibitor patent review: progress since 2011Semantic proximity Read ↗

STAT2 and IRF9Semantic proximity Read ↗

Advances and challenges in targeting IRF5, a key regulator of inflammationSemantic proximity Read ↗

Exposing the Two Contrasting Faces of STAT2 in InflammationSemantic proximity Read ↗

Strategies and Approaches of Targeting STAT3 for Cancer TreatmentSemantic proximity Read ↗

Novel inhibitors of signal transducer and activator of transcription 3 signaling pathway: an update on the recent patent literatureSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.